Retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist under clinical investigation for obesity, but it is not licensed by the MHRA or EMA in the UK
Geriatr Psychiatry 2018, 26 (3), 266277
EllieMD 01/21/2025 - 5 min read What is B12 and Who Should Take It
Hsu S, Brusca SB, Rhodes PS, Kolb TM, Mathai SC, Tedford RJ (2017) Use of thermodilution cardiac output overestimates diagnoses of exercise-induced pulmonary hypertension, (in eng)
Because food volume often drops on GLP-1s and aggressive cuts, relying solely on diet to hit those intakes can be tough
Uveal melanoma is rare (3.75% of all types of melanomas) and occurs as a result of malignant transformation of melanocytes at the choroid of the eyeball